SCHEMBL26062785

SCHEMBL26062785

COc1ccc(C2=CCOCC2)c(C)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNT1 O60563 1/20 0.41
▸ CDK9 P50750 1/20 0.41
▸ PDCD1 Q15116 1/20 0.39
▸ CD274 Q9NZQ7 1/20 0.39
▸ PDE3B Q13370 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ SUV39H2 Q9H5I1 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PDE10A Q9Y233 2/20 0.36
▸ GCK P35557 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ SCN9A Q15858 1/20 0.33
▸ PIK3CD O00329 3/20 0.33
▸ PIK3R1 P27986 3/20 0.33
▸ PIK3CA P42336 3/20 0.33
▸ PIK3CB P42338 3/20 0.33
▸ PIK3CG P48736 3/20 0.33
▸ MAPK14 Q16539 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28686966 0.80 EP300 (0.44) CCNT1CDK9SUV39H2GCKKDM4E
SCHEMBL18330519 0.80 SUV39H2 (0.44) CCNT1CDK9PDE3BPDE3ASUV39H2
SCHEMBL26062788 0.76 CCNT1 (0.33) CCNT1CDK9PDCD1CD274PDE3B
SCHEMBL20764947 0.76 TDP1 (0.38) CCNT1CDK9PDE3BPDE3ASUV39H2
SCHEMBL30439702 0.76 TDP1 (0.38) CCNT1CDK9PDE3BPDE3ASUV39H2
SCHEMBL16437271 0.74 SUV39H2 (0.40) CCNT1CDK9PDE3BPDE3ASUV39H2
SCHEMBL29889169 0.73 TUBB4A (0.45) CCNT1CDK9PDCD1CD274PDE3B
SCHEMBL26530979 0.72 PDCD1 (0.49) PDCD1CD274PDE3BPDE3APIK3CD
SCHEMBL20795222 0.71 CCNT1 (0.35) CCNT1CDK9PDE3BPDE3ASUV39H2
SCHEMBL12326162 0.71 ACHE (0.44) ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3672951-B1 QUINOXALINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2023-08-30 — — EP disclosed
Send feedback